Go back to Resources

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

2018 05 18

Journal Article

Authors:

Samai, M.

Seward, J.F.

Goldstein, S.T.

Mahon, B.E.

Lisk, D.Radcliffe

Widdowson, M.A.

Jalloh, M.I.

Schrag, S.J.

Idriss, A.

Carter, R.J.

Dawson, P.

Kargbo, S.A.S.

Leigh, B.

Bawoh, M.

Legardy-Williams, J.

Deen, G.

Carr, W.

Callis, A.

Lindblad, R.

Russell, J.B.W.

Petrie, C.R.

Fombah, A.E.

Kargbo, B.

McDonald, W.

Jarrett, O.D.

Walker, R.E.

Gargiullo, P.

Bash-Taqi, D.

Gibson, L.

Fofanah, A.Bakarr

Schuchat, A.

Secondary:
J Infect Dis

Volume:
217

Pagination:
S6-S15

Issue:
suppl_1

PMID:
29788345

DOI:
10.1093/infdis/jiy020

Keywords:
Adolescent; Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Ebola Vaccines; Epidemics; Female; Hemorrhagic Fever, Ebola; Humans; Longitudinal Studies; Male; Middle Aged; Sierra Leone; Vaccines, Synthetic; Young Adult

Abstract:
<p>Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].</p>

Go back to Resources